Am J Case Rep, 2023 · DOI: 10.12659/AJCR.938576 · Published: May 13, 2023
This case report evaluates the safety and effectiveness of using stem cells from Wharton's Jelly (WJ-MSCs) to treat a patient with a long-term, complete spinal cord injury. The study found the treatment to be safe, with no serious negative effects. The patient experienced improvements in both sensory and motor functions, and reported a better quality of life after receiving the stem cell injections. This suggests that WJ-MSCs could potentially help people with severe, long-lasting spinal cord injuries. Researchers believe the stem cells work by protecting the nerve cells that survived the initial injury, reducing inflammation, and encouraging the regeneration of damaged nerve tissue.
WJ-MSCs could be a safe and effective therapeutic strategy for chronic complete SCI.
The study supports the use of allogeneic MSCs in future clinical trials for patients with severe spine damage.
The observed improvements suggest that WJ-MSCs modulate inflammation, enhance natural healing in the CNS, and promote axonal growth.